Dr. Lal Pathlabs Ltd

NSE: LALPATHLAB · BSE: 539524 · Healthcare · 17 announcements

Share price: ₹1,952.30
Market cap: ₹32,769 Cr
Revenue (annual): ₹2,763 Cr
Net profit (annual): ₹504.8 Cr
P/E (TTM): 60.5×Sector 57.8×
Promoter holding: 53.19%-0.02% QoQ
FII holding: 17.35%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Acquisition 4 Other Announcement 3 Financial Results 2 Employee Stock Options 1 Earnings Call 1 Capital Structure Change 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

24 Jul 2026 14:14 IST BSE

Earnings Call

Dr. Lal Pathlabs Investor Presentation: Key Takeaways

Dr. Lal PathLabs reported strong Q1 FY27 results with 19.1% revenue growth and 27.2% PAT growth. Strategy remains focused on scientific leadership, patient experience, and operational excellence.

Open call summary → Read the filing ↗